Abpro Holdings Inc
ABP
Company Profile
Business description
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Contact
68 Cummings Park Drive
WoburnMA01801
USAT: +1 800 396-5890
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
6
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,741.90 | 26.70 | -0.30% |
| CAC 40 | 7,807.73 | 17.46 | 0.22% |
| DAX 40 | 24,324.77 | 1.19 | 0.00% |
| Dow JONES (US) | 42,877.22 | 557.48 | 1.32% |
| FTSE 100 | 8,843.78 | 32.74 | 0.37% |
| HKSE | 23,792.54 | 114.43 | -0.48% |
| NASDAQ | 19,557.61 | 259.16 | 1.34% |
| Nikkei 225 | 37,741.61 | 187.12 | 0.50% |
| NZX 50 Index | 12,563.48 | 13.67 | -0.11% |
| S&P 500 | 6,011.55 | 72.25 | 1.22% |
| S&P/ASX 200 | 8,515.70 | 23.20 | -0.27% |
| SSE Composite Index | 3,385.36 | 1.26 | 0.04% |